Drug Trial Radar · NCT03104400
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
Last checked: Nov 19, 2026Latest source record: Sep 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,705
Actual
Start
Apr 27, 2017
Primary completion
Sep 26, 2019
Study completion Sep 9, 2024
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Apr 7, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study includes two periods. The main objective of Period 1 is to compare the efficacy of upadacitinib 15 mg once daily (QD) and 30 mg QD versus placebo and versus adalimumab (Humira®) in participants with moderately to severely active psoriatic arthritis (PsA) who have had an inadequate response to non-biologic DMARDs (DMARD-IR). Period 1 is also designed to compare the efficacy of upadacitinib 15 mg and 30 mg QD versus placebo for the prevention of structural progression. The objective of Period 2 is to evaluate the long-term safety, tolerability and efficacy of upadacitinib 15 mg and 30 mg QD in participants who have completed Period 1.
Conditions
- Psoriatic Arthritis
Interventions
AdalimumabDrug
Administered by subcutaneous injection
UpadacitinibDrug
Oral tablet
Placebo to UpadacitinibDrug
Oral tablet
Placebo to AdalimumabDrug
Administered by subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 12Time frame: Baseline and Week 12
Locations
345 sites in 46 countries. Site status is shown where the registry gives one.
Rheum Assoc of North Alabama /ID# 163231
Huntsville, Alabama
SunValley Arthritis Center, Lt /ID# 161221
Peoria, Arizona
AZ Arthritis and Rheumotology Research, PLLC /ID# 159981
Phoenix, Arizona
AZ Arthritis and Rheumotology Research, PLLC /ID# 160033
Phoenix, Arizona
AZ Arthritis and Rheumotology Research, PLLC /ID# 160036
Phoenix, Arizona
AZ Arthritis & Rheuma Research /ID# 160037
Phoenix, Arizona
AZ Arth & Rheum Res /ID# 166381
Tucson, Arizona
Little Rock Diagnostics Clinic /ID# 165161
Little Rock, Arkansas
Covina Arthritis Clinic /ID# 159891
Covina, California
St. Joseph Heritage Healthcare /ID# 159980
Fullerton, California
C.V. Mehta MD, Med Corporation /ID# 161216
Hemet, California
Care Access Research, Huntingt /ID# 160038
Huntington Beach, California
Kotha and Kotha /ID# 159823
La Mesa, California
TriWest Research Associates- La Mesa /ID# 159887
La Mesa, California
Arthritis & Osteo Medical Ctr /ID# 166760
La Palma, California
University of California, Los Angeles /ID# 164542
Los Angeles, California
VA Sacramento Medical Center /ID# 164196
Mather, California
East Bay Rheumatology Medical /ID# 166382
San Leandro, California
Inland Rheum Clin Trials Inc. /ID# 159828
Upland, California
Medvin Clinical Research /ID# 160034
Whittier, California
Denver Arthritis Clinic /ID# 159873
Denver, Colorado
Arthritis and Rheum Clin N. CO /ID# 160039
Fort Collins, Colorado
Colorado Arthritis Associates /ID# 159847
Lakewood, Colorado
Stamford Therapeutics Consorti /ID# 165131
Stamford, Connecticut
Clinical Res of West FL, Inc. /ID# 159829
Clearwater, Florida
International Medical Research - Daytona /ID# 160040
Daytona Beach, Florida
Omega Research Maitland, LLC /ID# 164193
DeBary, Florida
LeJenue Research Associates /ID# 170965
Miami, Florida
Precision Research Org, LLC /ID# 161287
Miami Lakes, Florida
Medallion Clinical Research Institute, LLC /ID# 161228
Naples, Florida
Millennium Research /ID# 159822
Ormond Beach, Florida
Arthritis Center, Inc. /ID# 163465
Palm Harbor, Florida
Gulf Region Clinical Res Inst /ID# 159851
Pensacola, Florida
BayCare Medical Group /ID# 159792
St. Petersburg, Florida
W. Broward Rheum Assoc Inc. /ID# 161388
Tamarac, Florida
Clinical Research of West Florida, Inc /ID# 160063
Tampa, Florida
University of South Florida /ID# 161286
Tampa, Florida
BayCare Medical Group, Inc. /ID# 159879
Tampa, Florida
Florida Medical Clinic /ID# 159992
Zephyrhills, Florida
Institute of Arthritis Researc /ID# 165873
Idaho Falls, Idaho
Showing 40 of 345 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.